Apoptosis and fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma

Abstract

To investigate the roles of apoptosis and the Fas system (Fas, Fas ligand, soluble Fas) in the process of liver cirrhosis (LC) converting into hepatocellular carcinoma (HCC), expression of Fas and Fas ligand (FasL) in 49 LC and 36 HCC samples was detected by immunohistochemical method. Apoptosis was detected by terminal deoxynucleotidyl transferase mediated dUTP nick end labeling (TUNEL) method. Serum soluble Fas (sFas) levels in 28 cases of LC and 27 cases of HCC were measured by enzyme-linked immunosorbent assay (ELISA) method. Compared with LC. apoptotic indices (AI) in HCC tissues were significantly reduced (P< 0.001), expression of Fas was decreased (P< 0.05), and that of FasL was increased (P< 0.05). Serum sFas levels in HCC patients were significantly higher than those in normal controls. Down-regulation of Fas expression, up-regulation of FasL expression in hepatocytes and elevation of sFas level in serum might contribute to tumor escape from immune surveillance of the body. Apoptosis and the Fas system are significantly involved in the process of liver cirrhosis converting into hepatocellular carcinoma.

Keywords

hepatocellular carcinoma / liver cirrhosis / apoptosis / Fas / Fas ligand / soluble Fas

References

[1] YuZ Y, TangZ Y, YangB H, et al.. Viral hepatitis (HBV and HCV) background in Chinese patients with hepatocellular carcinoma. Clin J Cancer Res, 1994, 6: 79-79

[2] WilliamsG T. Programmed cell death: apoptosis and oncogenesis. Cell, 1991, 65: 1097-1097

[3] NagataS, GolsteinP. The Fas death factor. Science, 1995, 267: 1449-1449

[4] HayashiN, MitaE. Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol, 1997, 12: S223-S223

[5] Schulte-hermannR, BruschW, Grasl-krauppB, et al.. Active cell death (apoptosis) in liver biology and disease. Progress in liver disease, 1995, 13: 1-1

[6] BenedettiA, JezequelA M, OrlandiF. A quantitative evaluation of apoptotic bodies in rat liver. Liver, 1988, 8: 172-172

[7] Grasl-KrauppB, BurschW, Ruttkay-NedeckyB, et al.. Food restriction eliminates preneoplastic cells through apoptosis and antagonizes carcinogenesis in rat liver. Proc Natl Acad Sci USA, 1994, 91: 9995-9995

[8] OgasawaraJ, Watanabe-FukunagaR, AdachiM, et al.. Lethal effect of the anti-Fas antibody in mice. Nature, 1993, 364: 806-806

[9] GalleP R, HofmannW J, WalczakH, et al.. Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med, 1995, 182: 1223-1223

[10] ItoY, TakedaT, UmeshitaK, et al.. Fas antigen expression in hepatocellular carcinoma tissues. Oncol Reports, 1998, 5: 41-41

[11] YanoH, FukudaK, HaramakiM, et al.. Expression of Fas and anti-Fas-mediated apoptosis in human hepatocellular carcinoma cell lines. J Hepatol, 1996, 25: 454-454

[12] PapoffG, CascinoI, EramoA, et al.. An N-terminal domain shared by Fas/APO-1 (CD95) soluble variants prevents cell deathin vitro. J Immunol, 1996, 156: 4622-4622

[13] HanabuchiS, KoyanagiM, KawasakiA, et al.. Fas and its ligand in a general mechanism of T-cell-mediated cytotoxicity. Proc Natl Acad SciUSA, 1994, 91: 4930-4930

[14] GregoryP, MidisYu S, et al.. Elevated soluble Fas (sFas) levels in nonhematopoietic human malignancy. Cancer Research, 1996, 56: 3870-3870

[15] JodoS, KobayashiS, NakajimaY, et al.. Elevated serum levels of soluble Fas/APO-1 (CD95) in patients with hepatocellular carcinoma. Clin Exp Immunol, 1998, 112: 166-166